Otsuka group company Taiho Pharmaceutical has submitted for Japanese approval for TAS-116 (pimitespib), as a treatment for people with gastrointestinal stromal tumor (GIST). 14 September 2021
Spanish drugmaker PharmaMar says that the World Health Organization (WHO) has confirmed the International Nonproprietary Name (INN) of its investigational anti-tumor compound PM14 as ecubectedin. 13 September 2021
The US Food and Drug Administration has granted Breakthrough Therapy designation for Jardiance (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer Ingelheim and partner Eli Lilly announced today. 9 September 2021
In its weekly newsletter, the USA’s Institute for Clinical and Economic Review (ICER) noted that, on July 9, the Biden administration directed Health and Human Services (HHS) Secretary Xavier Becerra to develop a “comprehensive” plan on drug pricing reform within 45 days -- a deadline that came and went earlier this week. 27 August 2021
Japanese drugmaker Otsuka Pharmaceutical today announces it has received regulatory approval in Japan for a once-daily form in pediatric patients of Busulfex (busulfan) Injection 60mg. 25 August 2021
Bristol Myers Squibb stalwart Scott Cooke has been named the company’s general manager for the UK and Ireland, replacing Lynelle Hoch who has been promoted into a new role at the group’s corporate headquarters in the USA. 18 August 2021
Following a public consultation, the UK’s Medicine and Healthcare products Regulatory Agency (MHRA) is making Nuromol, which ontains 200mg of ibuprofen and 500mg of paracetamol per tablet, available as a General Sales medicine, meaning it can be bought without the need to visit a pharmacy. 17 August 2021
The Brazilian research institute Fiocruz has announced the signing of an agreement with the regional government and State University of Ceará for the development and production of the HH-120-Defenser vaccine against COVID-19. 16 August 2021
Bayer today announced Prof Dr Dominik Ruettinger as the new head of research and early development for oncology at its Pharmaceuticals Division, effective October 1, 2021. 26 July 2021
Spain’s largest drugmaker Almirall says it has received approval from the European Commission for Klisyri (tirbanibulin) for the topical treatment of actinic keratosis (AK) on the face or scalp in adults. 21 July 2021
Portuguese drugmaker BIAL and Slovenia-based Medis Pharmaceutical Company have entered into an exclusive partnership on two central nervous system drugs. 19 July 2021
Germany’s Merck KGaA has entered into a contract manufacturing agreement with Universal Corporation, Kenya, a subsidiary of India’s Strides Pharma Science, for the large-scale production of a new pediatric medication, once it has been registered. 15 July 2021
Global law firm Hogan Lovells said today it has secured an important victory before the Commercial Court of London, UK, for its client Acerus, a Canadian-based specialty pharmaceuticals company, against Recipharm Limited. 12 July 2021
French ophthalmology company Nicox’ shares edged up 1.5% to 3.85 euros today, after it announced that it has amended its March 2019 license agreement with China’s Ocumension Therapeutics, under which the latter has exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. 5 July 2021
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
India's Central Drugs Standard Control Organization (CDSCO) has provided a favorable recommendation for its novel antibiotic Miqnaf (nafithromycin) discovered and developed for the treatment of community-acquired bacterial pneumonia (CABP) in adults. 14 October 2024
The Danish Medicines Council (Medicinrådet), responsible for evaluating and recommending new treatments for Denmark’s healthcare system, is facing a significant increase in processing times. 14 October 2024
The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) have signed a Memorandum of Understanding (MoU), which will strengthen collaboration between the two health product regulators. 14 October 2024
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pfizer is to present initial findings from its CULTIVATE study of its sphingosine-1-phosphate (S1P) receptor modulator Velsipity (etrasimod) in Crohn’s disease (CD) at United European Gastroenterology Week 2024. 11 October 2024
Switzerland-based KeyBioscience and US pharma major Eli Lilly have agreed to extend their collaboration on the development of dual amylin calcitonin receptor agonists (DACRA), a new class of potential treatments for obesity and related disorders. 11 October 2024